Brief: Eiger Biopharmaceuticals Enters Into Open Market Agreement To Offer And Sell Shares Of Up To $50 Mln
25/03/2022 20:29
March 25 (Reuters) - Eiger BioPharmaceuticals Inc EIGR.O :
* EIGER BIOPHARMACEUTICALS INC - ENTERED INTO AN OPEN
MARKET SALE
AGREEMENT TO OFFER AND SELL, SHARES OF UP TO $50.0 MILLION
Further company coverage: EIGR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview